Literature DB >> 20633017

Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events.

Wei Qin1, Jennifer A Chan, Harry V Vinters, Gary W Mathern, David N Franz, Bruce E Taillon, Pascal Bouffard, David J Kwiatkowski.   

Abstract

Tuberous sclerosis complex (TSC) is an often severe neurocutaneous syndrome. Cortical tubers are the predominant neuropathological finding in TSC, and their number and location has been shown to correlate roughly with the severity of neurologic features in TSC. Past studies have shown that genomic deletion events in TSC1 or TSC2 are very rare in tubers, and suggested the potential involvement of the MAPK pathway in their pathogenesis. We used deep sequencing to assess all coding exons of TSC1 and TSC2, and the activating mutation hot spots within KRAS in 46 tubers from TSC patients. Germline heterozygous mutations were identified in 81% of tubers. The same secondary mutation in TSC2 was identified in six tuber samples from one individual. Further study showed that this second hit mutation was widely distributed in the cortex from one cerebral hemisphere of this individual at frequencies up to 10%. No other secondary mutations were found in the other 40 tubers analyzed. These data indicate that small second hit mutations in any of these three genes are very rare in TSC tubers. However, in one TSC individual, a second hit TSC2 point mutation occurred early during brain development, and likely contributed to tuber formation.
© 2010 The Authors; Brain Pathology © 2010 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633017      PMCID: PMC2951479          DOI: 10.1111/j.1750-3639.2010.00416.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  35 in total

1.  Complete inactivation of the TSC2 gene leads to formation of hamartomas.

Authors:  K S Au; A A Hebert; E S Roach; H Northrup
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Pathology of tuberous sclerosis. Neuropathologic aspects.

Authors:  E P Richardson
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.

Authors:  Y Niida; A O Stemmer-Rachamimov; M Logrip; D Tapon; R Perez; D J Kwiatkowski; K Sims; M MacCollin; D N Louis; V Ramesh
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

Review 4.  Pathogenesis of hereditary tumors: beyond the "two-hit" hypothesis.

Authors:  T Tucker; J M Friedman
Journal:  Clin Genet       Date:  2002-11       Impact factor: 4.438

5.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

6.  Markers of cellular proliferation are expressed in cortical tubers.

Authors:  Allana Lee; Michelle Maldonado; Marianna Baybis; Christopher A Walsh; Bernd Scheithauer; Raymond Yeung; Jack Parent; Howard L Weiner; Peter B Crino
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

7.  Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex.

Authors:  Michelle Maldonado; Marianna Baybis; David Newman; Dennis L Kolson; Wei Chen; Guy McKhann; David H Gutmann; Peter B Crino
Journal:  Neurobiol Dis       Date:  2003-11       Impact factor: 5.996

8.  Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions.

Authors:  Sangyeul Han; Túlio M Santos; Ana Puga; Jenn Roy; Elizabeth A Thiele; Mia McCollin; Anat Stemmer-Rachamimov; Vijaya Ramesh
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors.

Authors:  Karin Boer; Peter B Crino; Jan A Gorter; Mark Nellist; Floor E Jansen; Wim G M Spliet; Peter C van Rijen; Floyd R A Wittink; Timo M Breit; Dirk Troost; Wytse J Wadman; Eleonora Aronica
Journal:  Brain Pathol       Date:  2009-10-08       Impact factor: 6.508

10.  Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis.

Authors:  K Ridler; E T Bullmore; P J De Vries; J Suckling; G J Barker; S J Meara; S C Williams; P F Bolton
Journal:  Psychol Med       Date:  2001-11       Impact factor: 7.723

View more
  49 in total

1.  A Tuber-ful Animal Model of Tuberous Sclerosis At Last?

Authors:  Michael Wong
Journal:  Epilepsy Curr       Date:  2012-01       Impact factor: 7.500

2.  Tuber-Less Models of Tuberous Sclerosis Still Provide Insights Into Epilepsy.

Authors:  Michael Wong
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

Review 3.  mTOR signaling in epilepsy: insights from malformations of cortical development.

Authors:  Peter B Crino
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

4.  Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.

Authors:  Carlos Cepeda; Véronique M André; Jason S Hauptman; Irene Yamazaki; My N Huynh; Julia W Chang; Jane Y Chen; Robin S Fisher; Harry V Vinters; Michael S Levine; Gary W Mathern
Journal:  Neurobiol Dis       Date:  2011-08-23       Impact factor: 5.996

Review 5.  Malformations of cortical development and epilepsy.

Authors:  A James Barkovich; William B Dobyns; Renzo Guerrini
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

Review 6.  New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids.

Authors:  John D Blair; Helen S Bateup
Journal:  Dev Dyn       Date:  2019-05-23       Impact factor: 3.780

Review 7.  The role of somatic mutational events in the pathogenesis of epilepsy.

Authors:  Philip H Iffland; Peter B Crino
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

8.  Malformations of Cerebral Cortex Development: Molecules and Mechanisms.

Authors:  Gordana Juric-Sekhar; Robert F Hevner
Journal:  Annu Rev Pathol       Date:  2019-01-24       Impact factor: 23.472

9.  Neural progenitors derived from Tuberous Sclerosis Complex patients exhibit attenuated PI3K/AKT signaling and delayed neuronal differentiation.

Authors:  Avery J Zucco; Valentina Dal Pozzo; Alina Afinogenova; Ronald P Hart; Orrin Devinsky; Gabriella D'Arcangelo
Journal:  Mol Cell Neurosci       Date:  2018-08-23       Impact factor: 4.314

Review 10.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.